ATS 2024 Final Program

Click on the session title to view the speakers

130

MONDAY • MAY 20

1011 Perceptions of Interprofessional Staffing in Adult ICUs: Clinicians Feel Unsafe and Demoralized

111 Clinical Implications of the New Hemodynamic Definition of Precapillary Pulmonary Hypertension 112 AI-powered Quantification of Microvascular Remodeling: A Novel Marker for PH 113 Metabolic Insights into Pulmonary Artery Activity in Patients With Obstructive Sleep Apnea Before and After CPAP Therapy 114 Association Between Cardiopulmonary Hemodynamics and Morality in Veterans With Liver Cirrhosis 115 Genetic and Epigenetic Regulators of COL18A1 Expression in Preclinical Pulmonary Hypertension B25 LUNG INVOLVEMENT IN SICKLE CELL DISEASE AND AFTER HEMOPOIETIC STEM CELL TRANSPLANT 9:15 a.m. - 11:15 a.m. San Diego Convention Center Room 25A-C (Upper Level) Poster Viewing 9:15-10:00 Discussion 10:00-11:15 401 Sickle Cell Disease Microbiologic and Immunologic Links to Health Equity (SMILE) 402 Sickle Cell Disease and Fungal Asthma: A Complex Coupling 403 Effects of Adoption of Race Neutral Predictive Equations on Spirometry Results in Pediatric Sickle Cell Patients 404 Pulmonary Care for Children With Sickle Cell Disease: Spirometry, Reference Equations, and Equity 405 Impact of Using New Formula for Calculation of BASIC • CLINICAL • TRANSLATIONAL POSTER DISCUSSION SESSION Bronchodilator Response and Race-neutral Predictive Equations on Spirometry Results of Children With Sickle Cell Disease Echocardiography Is Associated With Sleep Disordered Breathing in Children With Sickle Cell Disease 406 Increased Tricuspid Regurgitation on

BASIC • CLINICAL • TRANSLATIONAL RAPID POSTER DISCUSSION SESSION

B24 WHALE WATCHING: A “RAPID” TOUR OF PAH PATHOGENESIS 9:15 a.m. - 11:15 a.m. Marriott Marquis San Diego Marina Pacific Ballroom 15-17 (Ground Floor, North Tower) Viewing/Discussion 9:15-10:00 Abstract Summaries 10:00-11:15 101 Right Ventricular Pulmonary Arterial Coupling Measured by Multi-beat Pressure Volume Loops Predicts Survival in Pulmonary Hypertension 102 Targeting the Stratifin Mediated Endothelial -Pericyte Crosstalk Ameliorates Pulmonary Hypertension 103 BRCC3 Regulation of ALK2 in Vascular Smooth Muscle Cells: Implication in Pulmonary Hypertension 104 Impact of PAH Therapies on Blood Vessel Volumes 105 The RNA M 6 A Demethylase, FTO, Regulates Vascular Remodeling in the Pathogenesis of Pulmonary Arterial Hypertension 106 Reduced Endothelial Cpt1a Causes Endomt and Pulmonary Vascular Remodeling in a Murine Model of Bronchopulmonary Dysplasia-associated Pulmonary Hypertension 107 Crosstalk Between Recruited and Resident Interstitial Macrophages in Schistosoma-induced Pulmonary Hypertension 108 Prediction of Response to Treprostinil Therapy in Patients With Pulmonary Hypertension Due to Interstitial Lung Disease Using Key Echocardiographic Parameters and Machine Learning 109 Pulmonary Hypertension Following Kidney Transplantation Is Common and Associated With Increased Mortality 110 Different Proteomic Profiles in Severe Pulmonary Hypertension Associated With COPD and Pulmonary Fibrosis

ATS 2024 Conference Program • San Diego, CA